The role of research in supporting Health Technology Assessment

The Health Technology Assessment Policy and Methods Review is a commitment in the 2022-2027 Strategic Agreement between the Commonwealth and Medicines Australia being conducted by the Department of Health.

The HTA Review is being undertaken by a Reference Committee. In this initial phase of the consultation, the Committee has sought feedback on specific questions, with responses to be made by electronic submission.

Research Australia has responded to two questions in the survey, highlighting the role that research in HTA can play in improving Australia’s system for HTA.

Research Australia’s submission is available here.

Research Australia looks forward to responding to the Reference Committee’s draft recommendations for change in the next phase of the Review.

Doubling Philanthropy by 2030

The Commonwealth Government has set an ambitious target to double philanthropic giving by 2023 and has asked the Productivity Commission (PC) to advise on how this can be achieved. The PC has launched an Inquiry, and in this first phase it is seeking data on philanthropy and ideas on actions the Government can take to achieve this goal.

Philanthropy plays a critical role in funding health and medical research and innovation in Australia. Research Australia’s submission has provided information about the nature of philanthropy in our sector and the role it plays in complementing other sources of funding. We have drawn on our many years of annual opinion polling to provide information about motivations for donating to research, tax deductions, trends in donations and attitudes to charities partnering with government to jointly fund research.

We have suggested that a more strategic approach by the Australian Government to working with charities could lead to efficiencies and greater effectiveness in the funding of HMR.

Research Australia’s submission is available here.

We will also respond to the second stage of the PC’s Inquiry, later in 2023. If you would like to join our working group on philanthropy, please email Greg Mullins, Head of Policy, at

Research is central to the Universities Accord

Research Australia’s submission to the Universities Accord Discussion paper responds to two key issues. The first relates to the career prospects and professional development of early and mid-career researchers. Research Australia proposes that this be a shared responsibility of research funders, universities, researcher managers and researchers. We also welcome further consideration of programs to support exposure to roles in industry and government during the completion of a higher degree by research.

The second relates to the funding for indirect research costs. We propose a new structure for the future funding of direct and indirect research costs and two distinct principles to guide the structure. We also propose that funding for national research infrastructure be included in these deliberations.

In each proposal we outline the case for how and why these issues should be addressed by an Accord between universities and the Commonwealth Government.

Research Australia’s submission is available here.

Australia’s future includes medical products manufacturing

The Science and Industry Minister asked the House Standing Committee on Industry, Science and Resources to conduct an Inquiry into developing advanced manufacturing (AM) in Australia. The Terms of Reference include:

    • opportunities in relation to job creation and productivity;
    • international trends;
    • Australia’s competitive strengths and advantages;
    • barriers to existing manufacturers, particularly SMEs
    • financial and non-financial investment opportunities or possible reforms to support the growth of AM
    • opportunities to increase employment in AM; and
    • skills needed in advanced manufacturing.

Research Australia’s submission has responded in relation to the opportunities and challenges for manufacturing medical products in Australia. We have called for a National Medical Products Industry Plan, with a goal of making Australia a net exporter of medical products, supported by a medical products workforce plan.

Research Australia’s submission is available here.

Reforming the Privacy Act to better support health research

The Attorney General’s Department is undertaking a multi stage review of the Privacy Act 1988. In February 2023 the Department published the Report of the Review of the Privacy Act and of the consultation undertaken in 2021 and 2022. The Report contains many proposals for amendment of the Act, a few of which have direct implications for the use of personal information in research, and consent to the use of information for research purposes. Research Australia responded to these privacy related matters, supporting a broder research consent, and further consultation on the exceptions from consent which permit research to be undertaken.

Research Australia’s submission is available here.

The Government’s response to the report was released on September 2023 and is available here. The Government has accepted the report’s recommendations relating to research and will consult further before developing legislation. Research Australia will continue to participate with further consultations as legislation is developed.

Making better use of GP Data and enhancing GP decision making

Most GPs these days use a practice management system (PMS), software which helps capture and manage patient information. Many of these systems also use AI enabled Clinical Decision Support (eCDS) software to support clinical decision making by suggesting possible diagnoses and treatments.

The Australian Government is investigating options for making greater use of data held in PMSs, and also the options for oversight of the quality of eCDS.  Research Australia’s submission has provided examples of the types of research outcomes that can be achieved with GP data, and suggested how research could support the validation of eCDS and confidence in its effectiveness.

Research Australia’s submission is available here.

Making better use of Health Identifiers for research

The Health Identifiers Review is being conducted by the Department of Health, with the objective of increasing the usage of Health Identifiers in the health system. Research Australia is seeking an amendment to the Health Identifiers Act to explicitly permit Health Identifiers to be used when preparing datasets for research purposes.

Research Australia’s response to the consultation is available here.

Research Australia urges Senate to support the National Reconstruction Fund

Research Australia has used its submission to the Senate Economics Legislation Committee Inquiry into the National Reconstruction Fund Bill to urge the Committee to recommend the passage of the Bill, subject to two amendments proposed by Research Australia.

Research Australia believes the National Reconstruction Fund provides the opportunity to better leverage Australia’s world leading health and medical research and create a vibrant and successful medical products industry which propels Australia forward to become a net exporter of medical products.

Doing so would provide significant benefits for Australians with more secure access to medical products, better health outcomes and the creation of well-paying jobs and new businesses in a sector that has enormous scope for ongoing global growth.

The proposed amendments are:

    • require the Ministers to report to the Parliament on how the NRF has complemented other measures by the Government to support research, innovation and manufacturing. (Clause 91)
    • require the quarterly investment reports to identify recipients of financial accommodation by name and to specify the priority area to which the financial accommodation relates. (Clause 82)

Research Australia’s submission is available here.

Research Australia responds to NRF Implementation

Research Australia believes the National Reconstruction Fund (NRF) has a vital role to play in creating a mature and vibrant domestic medical products industry as a cornerstone of a post-carbon Australian economy.

We have made four recommendations in response to the consultation on the implementation of the NRF:

    1. The Ministers should obtain the advice of a future Centre for Disease Control about medical products for which there is a critical unmet need for domestic manufacturing. This should be a consideration in how funds are subsequently allocated by the NRF, although not to the exclusion of the need to generate a return on the investment.
    2. Development of the investment mandate for the priority area of medical products should include identification of areas with the potential for profitable domestic manufacturing. This should be a consideration in how funds are subsequently allocated by the NRF, although not to the exclusion of the need to generate a return on the investment.
    3. The Australian Government should create a National Medical Products Industry Plan to accompany the introduction of the National Reconstruction Fund to make the most of all the Government’s investments throughout the health and medical research and development pipeline.
    4. The Australian Government should develop a medical products research, development and manufacturing workforce plan to determine where the gaps in existing skills are and to address them.

Research Australia’s submission addresses most of the questions posed in the consultation paper. The submission is available here


Dementia Action Plan needs new funding for research

The Australian Government’s draft Dementia Action Plan has recognised the importance of more research to improving the lives of those living with dementia, their family and carers but has not proposed any actions that will lead to more research being funded.

Research Australia’s submission has addressed this shortfall, and proposed the draft Dementia Research Strategy draw on the work undertaken by the now defunct NHMRC National Institute for Dementia Research. We have also recommended the proposed Australian Dementia Research Strategy be an ‘Australian Dementia Research, Innovation and Implementation Strategy’ to better meet the Action Plan’s objective of maximising the impact of research and innovation. Accountability for implementation of research outcomes and the funding of this activity needs to be clearly assigned by the Action Plan and the Strategy.

Research Australia’s submission is available here.